Cargando…

Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study

BACKGROUND: 70%–84% of individuals with antipsychotic treatment resistance show non-response from the first episode. Emerging cross-sectional evidence comparing cognitive profiles in treatment resistant schizophrenia to treatment-responsive schizophrenia has indicated that verbal memory and language...

Descripción completa

Detalles Bibliográficos
Autores principales: Millgate, Edward, Kravariti, Eugenia, Egerton, Alice, Howes, Oliver D, Murray, Robin M, Kassoumeri, Laura, Donocik, Jacek, Lewis, Shôn, Drake, Richard, Lawrie, Stephen, Murphy, Anna, Collier, Tracy, Lees, Jane, Stockton-Powdrell, Charlotte, Walters, James, Deakin, Bill, MacCabe, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627394/
https://www.ncbi.nlm.nih.gov/pubmed/34824121
http://dx.doi.org/10.1136/bmjopen-2021-054160
_version_ 1784606846006329344
author Millgate, Edward
Kravariti, Eugenia
Egerton, Alice
Howes, Oliver D
Murray, Robin M
Kassoumeri, Laura
Donocik, Jacek
Lewis, Shôn
Drake, Richard
Lawrie, Stephen
Murphy, Anna
Collier, Tracy
Lees, Jane
Stockton-Powdrell, Charlotte
Walters, James
Deakin, Bill
MacCabe, James
author_facet Millgate, Edward
Kravariti, Eugenia
Egerton, Alice
Howes, Oliver D
Murray, Robin M
Kassoumeri, Laura
Donocik, Jacek
Lewis, Shôn
Drake, Richard
Lawrie, Stephen
Murphy, Anna
Collier, Tracy
Lees, Jane
Stockton-Powdrell, Charlotte
Walters, James
Deakin, Bill
MacCabe, James
author_sort Millgate, Edward
collection PubMed
description BACKGROUND: 70%–84% of individuals with antipsychotic treatment resistance show non-response from the first episode. Emerging cross-sectional evidence comparing cognitive profiles in treatment resistant schizophrenia to treatment-responsive schizophrenia has indicated that verbal memory and language functions may be more impaired in treatment resistance. We sought to confirm this finding by comparing cognitive performance between antipsychotic non-responders (NR) and responders (R) using a brief cognitive battery for schizophrenia, with a primary focus on verbal tasks compared against other measures of cognition. DESIGN: Cross-sectional. SETTING: This cross-sectional study recruited antipsychotic treatment R and antipsychotic NR across four UK sites. Cognitive performance was assessed using the Brief Assessment of Cognition in Schizophrenia (BACS). PARTICIPANTS: One hundred and six participants aged 18–65 years with a diagnosis of schizophrenia or schizophreniform disorder were recruited according to their treatment response, with 52 NR and 54 R cases. OUTCOMES: Composite and subscale scores of cognitive performance on the BACS. Group (R vs NR) differences in cognitive scores were investigated using univariable and multivariable linear regressions adjusted for age, gender and illness duration. RESULTS: Univariable regression models observed no significant differences between R and NR groups on any measure of the BACS, including verbal memory (ß=−1.99, 95% CI −6.63 to 2.66, p=0.398) and verbal fluency (ß=1.23, 95% CI −2.46 to 4.91, p=0.510). This pattern of findings was consistent in multivariable models. CONCLUSIONS: The lack of group difference in cognition in our sample is likely due to a lack of clinical distinction between our groups. Future investigations should aim to use machine learning methods using longitudinal first episode samples to identify responder subtypes within schizophrenia, and how cognitive factors may interact within this. TRAIL REGISTRATION NUMBER: REC: 15/LO/0038.
format Online
Article
Text
id pubmed-8627394
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86273942021-12-10 Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study Millgate, Edward Kravariti, Eugenia Egerton, Alice Howes, Oliver D Murray, Robin M Kassoumeri, Laura Donocik, Jacek Lewis, Shôn Drake, Richard Lawrie, Stephen Murphy, Anna Collier, Tracy Lees, Jane Stockton-Powdrell, Charlotte Walters, James Deakin, Bill MacCabe, James BMJ Open Mental Health BACKGROUND: 70%–84% of individuals with antipsychotic treatment resistance show non-response from the first episode. Emerging cross-sectional evidence comparing cognitive profiles in treatment resistant schizophrenia to treatment-responsive schizophrenia has indicated that verbal memory and language functions may be more impaired in treatment resistance. We sought to confirm this finding by comparing cognitive performance between antipsychotic non-responders (NR) and responders (R) using a brief cognitive battery for schizophrenia, with a primary focus on verbal tasks compared against other measures of cognition. DESIGN: Cross-sectional. SETTING: This cross-sectional study recruited antipsychotic treatment R and antipsychotic NR across four UK sites. Cognitive performance was assessed using the Brief Assessment of Cognition in Schizophrenia (BACS). PARTICIPANTS: One hundred and six participants aged 18–65 years with a diagnosis of schizophrenia or schizophreniform disorder were recruited according to their treatment response, with 52 NR and 54 R cases. OUTCOMES: Composite and subscale scores of cognitive performance on the BACS. Group (R vs NR) differences in cognitive scores were investigated using univariable and multivariable linear regressions adjusted for age, gender and illness duration. RESULTS: Univariable regression models observed no significant differences between R and NR groups on any measure of the BACS, including verbal memory (ß=−1.99, 95% CI −6.63 to 2.66, p=0.398) and verbal fluency (ß=1.23, 95% CI −2.46 to 4.91, p=0.510). This pattern of findings was consistent in multivariable models. CONCLUSIONS: The lack of group difference in cognition in our sample is likely due to a lack of clinical distinction between our groups. Future investigations should aim to use machine learning methods using longitudinal first episode samples to identify responder subtypes within schizophrenia, and how cognitive factors may interact within this. TRAIL REGISTRATION NUMBER: REC: 15/LO/0038. BMJ Publishing Group 2021-11-25 /pmc/articles/PMC8627394/ /pubmed/34824121 http://dx.doi.org/10.1136/bmjopen-2021-054160 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Mental Health
Millgate, Edward
Kravariti, Eugenia
Egerton, Alice
Howes, Oliver D
Murray, Robin M
Kassoumeri, Laura
Donocik, Jacek
Lewis, Shôn
Drake, Richard
Lawrie, Stephen
Murphy, Anna
Collier, Tracy
Lees, Jane
Stockton-Powdrell, Charlotte
Walters, James
Deakin, Bill
MacCabe, James
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
title Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
title_full Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
title_fullStr Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
title_full_unstemmed Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
title_short Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
title_sort cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the strata study
topic Mental Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627394/
https://www.ncbi.nlm.nih.gov/pubmed/34824121
http://dx.doi.org/10.1136/bmjopen-2021-054160
work_keys_str_mv AT millgateedward crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT kravaritieugenia crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT egertonalice crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT howesoliverd crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT murrayrobinm crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT kassoumerilaura crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT donocikjacek crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT lewisshon crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT drakerichard crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT lawriestephen crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT murphyanna crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT colliertracy crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT leesjane crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT stocktonpowdrellcharlotte crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT waltersjames crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT deakinbill crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy
AT maccabejames crosssectionalstudycomparingcognitivefunctionintreatmentresponsiveversustreatmentnonresponsiveschizophreniaevidencefromthestratastudy